• Product nameAnti-Ube2L3 antibody
    See all Ube2L3 primary antibodies
  • Description
    Goat polyclonal to Ube2L3
  • Tested applicationsSuitable for: ELISA, WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Chicken, Cow, Xenopus laevis, Zebrafish
  • Immunogen

    Synthetic peptide:


    , corresponding to C terminal amino acids 142/154 of Human Ube2L3

  • Positive control
    • Hela and Jurkat lysates



Our Abpromise guarantee covers the use of ab37913 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesELISA: antibody detection limit dilution 1/128000.
    WB: Use at a concentration of 0.5 - 2 µg/ml. Detects a band of approximately 18 kDa (predicted molecular weight: 18 kDa).

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionAccepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-linked polyubiquitination. Involved in the selective degradation of short-lived and abnormal proteins. Down-regulated during the S-phase it is involved in progression through the cell cycle. Regulates nuclear hormone receptors transcriptional activity. May play a role in myelopoiesis.
    • Tissue specificityUbiquitous, with highest expression in testis.
    • PathwayProtein modification; protein ubiquitination.
    • Sequence similaritiesBelongs to the ubiquitin-conjugating enzyme family.
    • Post-translational
      Ubiquitinated. The alteration of UBE2L3 protein levels during the S-phase of the cell cycle is due to ubiquitin-dependent proteasomal degradation.
    • Cellular localizationNucleus. Cytoplasm.
    • Information by UniProt
    • Database links
    • Alternative names
      • E2 F1 antibody
      • L UBC antibody
      • L-UBC antibody
      • UB2L3_HUMAN antibody
      • UBCE7 antibody
      • UbcH7 antibody
      • UbcM4 antibody
      • Ube2l3 antibody
      • Ubiquitin carrier protein L3 antibody
      • Ubiquitin conjugating enzyme E2 L3 antibody
      • Ubiquitin protein ligase L3 antibody
      • Ubiquitin-conjugating enzyme E2 L3 antibody
      • Ubiquitin-conjugating enzyme E2-F1 antibody
      • Ubiquitin-protein ligase L3 antibody
      see all

    Anti-Ube2L3 antibody images

    • All lanes : Anti-Ube2L3 antibody (ab37913) at 0.03 µg/ml

      Lane 1 : Human skeletal muscle lysate
      Lane 2 : Mouse skeletal muscle lysate
      Lane 3 : Rat skeletal muscle lysate

      Lysates/proteins at 35 µg per lane.

      Predicted band size : 18 kDa
    • All lanes : Anti-Ube2L3 antibody (ab37913) at 0.01 µg/ml

      Lane 1 : Human heart lysate at 0.01 µg
      Lane 2 : Mouse heart lysate at 35 µg
      Lane 3 : Rat heart lysate at 35 µg
      Lane 4 : Pig heart lysate at 35 µg

      Predicted band size : 18 kDa
    • Anti-Ube2L3 antibody (ab37913) at 0.5 µg/ml + Hela lysate (RIPA buffer) at 35 µg
      developed using the ECL technique

      Predicted band size : 18 kDa
      Observed band size : 18 kDa
      Primary incubated for 1 hour.

    References for Anti-Ube2L3 antibody (ab37913)

    This product has been referenced in:
    • Reyes-Hernández OD  et al. Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination. Biochem Pharmacol 80:932-40 (2010). WB ; Mouse . Read more (PubMed: 20478272) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab37913.
    Please use the links above to contact us or submit feedback about this product.